Europe Automated Sample Preparation Market to Grow with a CAGR of 8.55% through 2030
Focus on
reducing human error and improving accuracy is expected to drive the Europe Automated
Sample Preparation Market growth in the forecast period, 2026-2030.
According to
TechSci Research report, “Europe Automated Sample Preparation Market By
Country, Competition, Forecast and Opportunities, 2030”, the Europe Automated
Sample Preparation Market stood at USD 402.11 Million in 2024 and is expected to reach USD
659.39 Million by 2030 with a CAGR of 8.55% during the forecast period.
The Europe
Automated Sample Preparation Market is experiencing significant growth driven
by technological advancements, increasing demand for high-quality diagnostics,
and the evolving needs of research and clinical laboratories. In recent years,
automated sample preparation systems have become essential tools for
laboratories dealing with high-throughput workflows and complex biological
samples. These systems play a crucial role in streamlining laboratory
processes, reducing human error, improving reproducibility, and ensuring the
accuracy of diagnostic and research outcomes.
One of the key
factors influencing the scenario of the Europe Automated Sample Preparation
Market is the increasing demand for precision medicine and personalized
healthcare. With the growing focus on individualized treatment plans,
especially in fields like oncology, genomics, and neurology, laboratories are
under pressure to process large volumes of biological samples quickly and
accurately. Automation has become a critical solution to meet these needs, as
traditional manual sample preparation methods are often slow, labor-intensive,
and prone to error. Automated systems, which can handle high-throughput
workflows and process complex samples with precision, are therefore highly
valued.
The rise of
genomics and molecular diagnostics has spurred the adoption of automated sample
preparation technologies. Next-generation sequencing and other molecular
diagnostic methods require high-quality, reproducible sample preparation to
ensure the reliability of test results. As Europe continues to invest in
genomic research and precision medicine, the demand for automated sample
preparation solutions is expected to grow. In addition, the increasing use of
biomarkers for disease detection and monitoring has led to a surge in the need
for automated systems that can prepare samples in a standardized and efficient
manner, particularly in areas like cancer diagnostics and genetic testing.
In terms of
market dynamics, the Europe Automated Sample Preparation Market is
characterized by a strong presence of both established players and emerging
startups. Established manufacturers, including Thermo Fisher Scientific,
Agilent Technologies, and Hamilton Company, dominate the market by offering a
wide range of automated sample preparation solutions for various applications,
from genomics and proteomics to drug discovery and clinical diagnostics. These
companies have been at the forefront of innovation, developing cutting-edge
systems that offer higher throughput, greater accuracy, and enhanced
flexibility. They are also investing in research and development to introduce
new products that cater to the evolving needs of the market, particularly in the
areas of high-throughput screening and personalized medicine.
In addition to
these well-established players, a growing number of startups and smaller
companies are entering the market with novel solutions designed to meet
specific needs in sample preparation. These companies are leveraging
advancements in robotics, artificial intelligence, and machine learning to
develop highly specialized, user-friendly systems that can be easily integrated
into existing laboratory workflows. This influx of innovation is driving
competition in the market, leading to continuous improvements in product
offerings. The demand for automated sample preparation solutions is also being
fueled by the increasing prevalence of chronic diseases in Europe, such as
cancer, cardiovascular diseases, and diabetes. As these diseases become more
prevalent, there is a corresponding need for more efficient diagnostic testing
and monitoring, which in turn drives the demand for high-quality sample
preparation systems. The aging population in Europe presents further
opportunities for market growth, as elderly individuals are more likely to
suffer from conditions that require regular medical testing and diagnostic
procedures.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on "
Europe Automated Sample Preparation Market”
Europe Automated
Sample Preparation Market is segmented into product type, application, end
user, country distribution, and company.
Based on end
user, biotechnology and pharmaceutical companies dominated due to their
extensive demand for high-throughput screening, drug discovery, and research.
These companies require efficient, accurate, and reproducible sample
preparation systems to support their growing need for large-scale processing of
biological samples, particularly in the fields of genomics, proteomics, and
molecular diagnostics. The growing emphasis on precision medicine, clinical
trials, and biologic drugs has led to an increasing reliance on automated
sample preparation technologies in the biotechnology and pharmaceutical
sectors.
These companies
are focused on developing new drugs and therapies that require consistent and
reproducible testing of biological samples, making the role of automated sample
preparation crucial in streamlining their R&D workflows. With the
increasing volume of clinical and preclinical data being generated, these
companies need systems capable of handling high-throughput workflows with
minimal errors and optimal efficiency. Automation enables pharmaceutical
companies to process large numbers of samples rapidly, reducing the time needed
for data generation and allowing researchers to focus on analysis and
interpretation.
Biotechnology
and pharmaceutical companies are increasingly turning to next-generation
sequencing (NGS), high-content screening, and mass spectrometry techniques, all
of which demand precise and accurate sample preparation. Automated systems are
ideal for these workflows as they ensure the necessary sample quality, reduce
variability, and minimize human error, thereby accelerating the development of
therapeutics and diagnostic tests. The demand for more complex biologic and
biosimilar drugs, as well as personalized medicines, has further driven the
need for automation in the pharmaceutical sector. This trend is expected to
continue, particularly with the rise of gene therapies and monoclonal
antibodies, where sample integrity and preparation are crucial to ensure the
success of experiments and clinical applications.
Based on country,
the United Kingdom was the second largest player in the Europe Automated Sample
Preparation Market, after Germany. The United Kingdom has a well-established
healthcare and life sciences sector, supported by its robust pharmaceutical,
biotechnology, and clinical research industries. As a leader in both academic
research and industrial applications, the country has seen significant adoption
of automated sample preparation technologies, particularly within
pharmaceutical, biotechnology, and academic research institutions.
The United
Kingdom's biotechnology and pharmaceutical companies are at the forefront of
drug discovery, molecular diagnostics, and precision medicine, which require
high-throughput screening, automated sample preparation, and precise data
analysis. The growing emphasis on biologics, personalized medicine, and
advanced therapies is driving the demand for automated sample preparation
systems. The presence of major pharmaceutical companies and research hubs in
the UK ensures a constant need for high-quality sample preparation
technologies.
One of the key
factors contributing to the United Kingdom’s dominance in the European
automated sample preparation market is its global leadership in pharmaceutical
research and development. The UK is home to a number of leading pharmaceutical
companies, such as GlaxoSmithKline, AstraZeneca, and Pfizer, which invest
heavily in research to develop innovative therapies. With the increasing
complexity of new drug development, particularly biologics, the demand for
automation in laboratories has surged. Automated sample preparation
technologies are crucial for handling the large number of biological samples
used in drug discovery, clinical trials, and personalized medicine initiatives.
The UK's thriving biotechnology industry plays an equally significant role in
driving the adoption of automated sample preparation technologies.
Biotechnology companies in the UK focus on research areas such as genomics,
proteomics, and molecular biology, all of which require accurate and efficient
sample processing. For example, next-generation sequencing (NGS) and
high-content screening are becoming increasingly prevalent in the country’s
biotechnology and pharmaceutical sectors. These technologies require automated
systems to prepare samples for analysis, which fuels the demand for
high-quality automated sample preparation solutions.
In addition to
biotechnology and pharmaceutical companies, the clinical research and academic
sectors in the United Kingdom also contribute to the growing market for
automated sample preparation systems. The UK has a strong academic research
environment, with universities such as the University of Cambridge, University
of Oxford, and Imperial College London conducting cutting-edge research in life
sciences and healthcare. These institutions often lead in the development and
adoption of new technologies, including automated systems for sample
preparation. The presence of well-funded research grants and collaborations
between academia and industry ensures that academic institutions are frequently
upgrading their research laboratories with state-of-the-art equipment.
Major companies
operating in Europe Automated Sample Preparation Market are:
- F. Hoffmann-La Roche Ltd
- Metrohm AG
- QIAGEN N.V.
- Tecan Trading AG
- SOTAX AG
- Promega GmbH
- Hitachi High-Tech Europe GmbH
- Labman Automation Ltd.
- Shimadzu France SAS
- Agilent Technologies Deutschland
GmbH
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The future of
the Europe Automated Sample Preparation Market looks promising, driven by
advancements in biotechnology, pharmaceutical research, and clinical
diagnostics. As the demand for high-throughput screening, precision medicine,
and personalized therapies grows, automation in sample preparation will become
increasingly critical to streamline laboratory workflows and enhance
efficiency. The rise of next-generation sequencing, genomics, and proteomics
will further accelerate the adoption of automated systems. Government
initiatives, increasing healthcare investments, and the need for
cost-effective, accurate results will propel market growth. With continuous
innovation in automation technologies and strong investments in healthcare
infrastructure, the Europe Automated Sample Preparation Market is poised for
substantial expansion in the coming years”, said Mr. Karan Chechi, Research
Director of TechSci Research, a research-based management consulting firm.
“Europe Automated Sample Preparation Market By Product Type (Kits & Consumables and Instruments), By Application (Research & Development and Diagnostics), By End User (Biotechnology & Pharmaceutical Companies, Clinical & Diagnostic Laboratories and Academic & Research Institutions), By Country, Competition, Forecast and Opportunities, 2020-2030F”, has evaluated the future growth potential of Europe
Automated Sample Preparation Market and provides statistics & information
on market size, structure and future market growth. The report intends to
provide cutting-edge market intelligence and help decision makers take sound
investment decisions. Besides, the report also identifies and analyzes the
emerging trends along with essential drivers, challenges, and opportunities in Europe
Automated Sample Preparation Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com